Financial Ratios | Aarti Drugs Ltd. | R Wadiwala Securities Pvt Ltd

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE496.252.95 (+0.6 %)
PREV CLOSE (Rs.) 493.30
OPEN PRICE (Rs.) 489.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11051
TODAY'S LOW / HIGH (Rs.)486.25 499.00
52 WK LOW / HIGH (Rs.)408.95 645
NSE495.002.65 (+0.54 %)
PREV CLOSE( Rs. ) 492.35
OPEN PRICE (Rs.) 490.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 104914
TODAY'S LOW / HIGH(Rs.) 485.55 499.10
52 WK LOW / HIGH (Rs.)409 645.75

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)17.9622.1430.0960.6938.06
   CEPS(Rs)23.4027.5435.4481.6156.11
   DPS(Rs)1.001.002.502.001.00
   Book NAV/Share(Rs)128.77111.9298.01280.04230.45
   Tax Rate(%)25.7924.0624.0123.6931.50
Margin Ratios
   Core EBITDA Margin(%)11.3913.3620.4414.7013.51
   EBIT Margin(%)9.6211.8118.3412.3311.18
   Pre Tax Margin(%)8.2510.8517.1310.268.39
   PAT Margin (%)6.128.2413.017.835.75
   Cash Profit Margin (%)7.9810.2515.3310.538.48
Performance Ratios
   ROA(%)7.1910.3216.789.336.31
   ROE(%)14.9321.0335.8123.6517.97
   ROCE(%)15.4920.7534.5221.3917.01
   Asset Turnover(x)1.171.251.291.191.10
   Sales/Fixed Asset(x)2.292.192.021.811.66
   Working Capital/Sales(x)4.865.494.676.548.07
Efficiency Ratios
   Fixed Capital/Sales(x)0.440.460.490.550.60
   Receivable days108.5095.7188.4195.7197.45
   Inventory Days70.0369.0062.7157.8061.36
   Payable days95.4990.2895.2792.6390.28
Valuation Parameters
   PER(x)18.8119.3723.092.084.21
   PCE(x)14.4415.5819.611.552.85
   Price/Book(x)2.623.837.090.450.69
   Yield(%)0.300.230.360.400.16
   EV/Net Sales(x)1.371.803.160.861.29
   EV/Core EBITDA(x)11.9513.0515.315.819.43
   EV/EBIT(x)14.2615.2717.236.9611.53
   EV/CE(x)1.542.033.861.501.91
   M Cap / Sales1.151.603.010.650.97
Growth Ratio
   Net Sales Growth(%)9.1415.4919.3115.7125.52
   Core EBITDA Growth(%)-9.38-22.7066.6325.165.13
   EBIT Growth(%)-11.07-25.6577.4727.617.17
   PAT Growth(%)-18.85-26.8998.3057.549.05
   EPS Growth(%)-18.89-26.41-50.4259.459.05
Financial Stability Ratios
   Total Debt/Equity(x)0.510.520.380.580.93
   Current Ratio(x)1.601.481.781.441.33
   Quick Ratio(x)1.050.921.080.920.91
   Interest Cover(x)7.0412.2915.075.954.01
   Total Debt/Mcap(x)0.190.140.050.320.34